The Cholesterol Lowering Effects of Strawberry
Public ClinicalTrials.gov record NCT02612090. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
The Cholesterol Lowering Effects of Strawberry: A Randomized Controlled Trial Establishing Strawberry's Role in Cardiovascular Health
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Primary objective is to assess strawberry intake on LDL cholesterol and its association with atherosclerosis development.
Study identification
- NCT ID
- NCT02612090
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 46 participants
Conditions and interventions
Conditions
Interventions
- Active Treatment Beverage Dietary Supplement
- Placebo Treatment Beverage Dietary Supplement
Dietary Supplement
Eligibility (public fields only)
- Age range
- 40 Years to 69 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 3, 2016
- Primary completion
- Jul 15, 2017
- Completion
- Oct 30, 2018
- Last update posted
- Jan 26, 2021
2016 – 2018
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Clinical Nutrition Research Center | Chicago | Illinois | 60616 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Hypercholesterolemia trials
Other public records listing Hypercholesterolemia. Sorted by last update posted; newest first. Not a recommendation.
- NCT07477704: A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia Recruiting
- NCT06451770: Phase 1b Study of VERVE-201 in Patients With Refractory Hyperlipidemia Recruiting
- NCT06065098: Church-based Health Intervention to Eliminate Racial Inequalities in Cardiovascular Health Active, not recruiting
- NCT00353782: Causes and Natural History of Dyslipidemias Recruiting
- NCT07447206: Vascular Intervention Strategies Trial for Alzheimer's Not yet recruiting
- NCT07514663: Assessing the Effects of Corn and Avocado Oils on the Cardiometabolic Risk Factor Profile Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02612090, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 26, 2021 · Synced Sep 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02612090 live on ClinicalTrials.gov.